DE69033521T2 - Verwendung von arginin als immunstimulator - Google Patents

Verwendung von arginin als immunstimulator

Info

Publication number
DE69033521T2
DE69033521T2 DE69033521T DE69033521T DE69033521T2 DE 69033521 T2 DE69033521 T2 DE 69033521T2 DE 69033521 T DE69033521 T DE 69033521T DE 69033521 T DE69033521 T DE 69033521T DE 69033521 T2 DE69033521 T2 DE 69033521T2
Authority
DE
Germany
Prior art keywords
arginine
ornithine
immune response
impaired
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69033521T
Other languages
English (en)
Other versions
DE69033521D1 (de
Inventor
Nobuo Yoshimura
Adrian Barbul
Chimei Tao
Craig Storm
Edward Kelly
Leah Reis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Medical Inc
Original Assignee
B Braun Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Braun Medical Inc filed Critical B Braun Medical Inc
Application granted granted Critical
Publication of DE69033521D1 publication Critical patent/DE69033521D1/de
Publication of DE69033521T2 publication Critical patent/DE69033521T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pediatric Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DE69033521T 1989-12-29 1990-12-28 Verwendung von arginin als immunstimulator Expired - Fee Related DE69033521T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45899689A 1989-12-29 1989-12-29
PCT/US1990/007689 WO1991009524A1 (en) 1989-12-29 1990-12-28 The use of arginine as an immunostimulator

Publications (2)

Publication Number Publication Date
DE69033521D1 DE69033521D1 (de) 2000-05-31
DE69033521T2 true DE69033521T2 (de) 2000-08-31

Family

ID=23822959

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69033521T Expired - Fee Related DE69033521T2 (de) 1989-12-29 1990-12-28 Verwendung von arginin als immunstimulator

Country Status (8)

Country Link
EP (1) EP0507872B1 (de)
JP (1) JP3287842B2 (de)
AT (1) ATE192037T1 (de)
AU (1) AU7148791A (de)
CA (1) CA2071971C (de)
DE (1) DE69033521T2 (de)
ES (1) ES2146199T3 (de)
WO (1) WO1991009524A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10128934A1 (de) * 2001-06-18 2003-02-06 Bernhard Sibbe Wirkstoffzusammensetzung zur Vorbeugung gegen Angina-Pectoris-Beschwerden
DE102022004219A1 (de) 2022-11-15 2024-05-16 Peter Meyer Aminosäurenkombination mit Vitamin C und B6 zur präventiven, kurativen und rehabilitativen Behandlung von Stoffwechselstörungen im Kohlenhydratstoffwechsel, Proteinstoffwechsel und Fettstoffwechsel sowie bei physischen und/oder psychischen Leistungsverlust.

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292773A (en) * 1990-02-14 1994-03-08 Hirsch Gerald P Treating aids and HIV infection with methionine
US5221668A (en) * 1992-02-26 1993-06-22 Abbott Laboratories Nutritional product for trauma and surgery patients
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
GB9510037D0 (en) * 1995-05-18 1995-07-12 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
IT1277897B1 (it) * 1995-08-03 1997-11-12 Mendes Srl Uso della l-carnitina,di suoi derivati e di loro sali farmaceuticamen- te accettabili in combinazione con farmaci antiretrovirali per ridurre
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
DE50010583D1 (de) * 1999-01-29 2005-07-28 Sportmedizin Team Vertriebs Gm Zusammensetzung zur Leistungsförderung bei sportlicher Tätigkeit, ihre Herstellung und Verwendung als diätetisches Lebensmittel
EP1176880B1 (de) 1999-04-27 2005-06-01 Aionix Investments Ltd. Zusatz für die wiederherstellung des wachstumhormonspiegels
EP1565195B1 (de) * 2002-10-31 2008-07-23 Lae-Ok Park Antikrebs- und antivirale zusammensetzung
JP4528925B2 (ja) * 2003-05-30 2010-08-25 独立行政法人理化学研究所 アミノ酸組成物及び補液
RU2469701C2 (ru) * 2008-02-08 2012-12-20 Колгейт-Палмолив Компани Продукт для ухода за полостью рта и способы его применения
WO2011021926A1 (en) 2009-08-21 2011-02-24 N.V. Nutricia Regulating the amino acid pool used for the acute-phase protein synthesis
KR20160084438A (ko) 2013-11-13 2016-07-13 노파르티스 아게 면역 반응을 강화하기 위한 mTOR 억제제
JP2016132622A (ja) * 2015-01-16 2016-07-25 イーエヌ大塚製薬株式会社 敗血症治療又は予防用栄養組成物
CA3011283A1 (en) 2016-01-11 2017-07-20 Synlogic Operating Company, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
CA3066109A1 (en) * 2017-07-12 2019-01-17 Synlogic Operating Company, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
EP3668328A4 (de) * 2017-08-18 2021-04-14 Calwood Nutritionals, LLC Zusammensetzungen und verfahren zur erhöhung der muskelmasse und der stärke, behandlung der haut, verminderung der abnutzung und des abbaus durch alterung und belastung und verbesserung der regeneration von stress wie training und trauma
KR20200083977A (ko) 2017-11-02 2020-07-09 바이오벤처스, 엘엘씨 개선된 근육 단백질 합성을 위한 아미노산 보충물의 이용
CN115279210A (zh) * 2020-04-06 2022-11-01 雀巢产品有限公司 活力膳食补充剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123413A (ja) * 1983-12-05 1985-07-02 Ajinomoto Co Inc 新アミノ酸輸液
IT1177384B (it) * 1984-12-12 1987-08-26 Boeehringer Biochemia Robin Sp Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione
JPS61186320A (ja) * 1985-02-12 1986-08-20 Morishita Seiyaku Kk アミノ酸製剤
DE3603242A1 (de) * 1986-02-03 1987-08-06 Deutsches Krebsforsch Verwendung von putrescin, ornithin und uridin allein oder in mischung, ggfs. zusammen mit lactat und/oder pyruvat zur steigerung der aktivitaet von helfer t-lymphozyten und davon abhaengiger anderer immunreaktionen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10128934A1 (de) * 2001-06-18 2003-02-06 Bernhard Sibbe Wirkstoffzusammensetzung zur Vorbeugung gegen Angina-Pectoris-Beschwerden
DE102022004219A1 (de) 2022-11-15 2024-05-16 Peter Meyer Aminosäurenkombination mit Vitamin C und B6 zur präventiven, kurativen und rehabilitativen Behandlung von Stoffwechselstörungen im Kohlenhydratstoffwechsel, Proteinstoffwechsel und Fettstoffwechsel sowie bei physischen und/oder psychischen Leistungsverlust.

Also Published As

Publication number Publication date
EP0507872A4 (en) 1993-08-04
ATE192037T1 (de) 2000-05-15
JPH05502881A (ja) 1993-05-20
CA2071971A1 (en) 1991-06-30
EP0507872B1 (de) 2000-04-26
CA2071971C (en) 2001-11-20
ES2146199T3 (es) 2000-08-01
WO1991009524A1 (en) 1991-07-11
JP3287842B2 (ja) 2002-06-04
EP0507872A1 (de) 1992-10-14
DE69033521D1 (de) 2000-05-31
AU7148791A (en) 1991-07-24

Similar Documents

Publication Publication Date Title
ATE192037T1 (de) Verwendung von arginin als immunstimulator
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
ES2152252T3 (es) Indolocarbazolimidas y su empleo.
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
DE69432027T2 (de) Verwendung von schilddrüsenhormone in ein medizinisches behandlungsverfahren
DE69027031D1 (de) Nicht glycosierte proteine, analoge des menschlichen interleukin-3
DE68912459T2 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten.
DE69929188D1 (de) Lysin enthaltende peptide zur behandlung von herzkrankheiten
ATE161882T1 (de) Molekulare klonierung und expression von menschlichem il-3
EA200000378A1 (ru) Усеченные по амино-концу мср-2 как антагонисты хемокинов
ATE87485T1 (de) Peptide der cholecystokinin-cerulein-gruppe enthaltende pharmazeutische zusammensetzungen zur behandlung von respiratorischen und herzkreislauf-insuffizienzen.
NO882239L (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
EP0339549A3 (de) Tyr-Peptid-Analoge
NO882238D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cykliske peptider.
DE69133077T2 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
ATE59781T1 (de) Potenzierung von prazosin.
UA42693C2 (uk) Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
AU3881889A (en) Human interferon-gamma, process to prepare said human interferon-gamma, and its use
DK0820308T3 (da) Konjugat til behandling af inflammatoriske sygdomme
SU1069818A1 (ru) Способ профилактики гриппа
ATE83931T1 (de) Methode fuer die behandlung von viraler gehirnentzuendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee